Surgery Partners.
healthcare services company
- Reports this week
- 0
- Active events
- 0
- Connections
- 40
What's happening
Earlier this month
-
Lumentum is being sold to Marvell Technology, while Surgery Partners is being sold to HealthSpan Partners.Some support1 report
-
Surgery Partners is being sold to HealthSpan Partners for $23.50 per share.Some support1 report
-
Surgery Partners and Fifth Third Bancorp announced increased holdings in company stock, requiring filing with the SEC on September 8, 2026.Some support5 reports
One to three months ago
Gone quiet
No new reports in 90+ days-
Surgery Partners underperformed the market so far this year, based on events of August 5, 2025.Some support2 reports
-
Surgery Partners is listed on NASDAQ and receives analyst ratings from MarketBeat.Some support2 reports
-
Cantor Fitzgerald is monitoring the performance of Surgery Partners, a healthcare services provider in the US. Raymond James Financial and TD Cowen are also providing price targets and buy ratings.Some support1 report
-
Surgery Partners (Q124668353) is expected to divest from Idaho Falls (Q496360) and operates on the Nasdaq stock exchange (Q82059).Some support1 report
-
Eric J. Evans was appointed CEO and Dave Doherty was appointed CFO of Surgery Partners on August 5, 2025.Some support2 reports
-
Surgery Partners is selling facilities to Intermountain Health.Some support1 report
-
Analyst reports from Jefferies Financial Group influence stock price targets for Surgery Partners.Some support2 reports
-
A tariff plan could affect the healthcare supply chain, impacting companies like Nobel Biocare and Cardinal Health.Some support2 reports
-
Surgery Partners and Pacific Biosciences were both mentioned in the context of healthcare industry performance in July 2025.Speculative1 report
-
Surgery Partners operates across 33 states in the US, and DaVita operates over 2,600 dialysis centers in the US.Some support1 report
-
Surgery Partners is headquartered in Brentwood, Tennessee, and uses Replay for conference call distribution.Some support2 reports
-
Surgery Partners's stock return outpaced the S&P 500 on July 22, 2025.Some support1 report
-
Surging medical costs are impacting the health insurance sector, involving companies like UnitedHealth Group, Molina Healthcare, Moderna, Oscar Health, and Surgery Partners.Some support2 reports2 developments inside
-
Surgery Partners rejected a buyout offer from Bain Capital, while Benchmark reiterated a 'Buy' rating on the company.Some support4 reports
-
Surgery Partners and Select Medical are identified as operating in the healthcare providers and services segment.Some support1 report
-
Surgery Partners and Lifestance Health are partnering, both of which operate in the outpatient and specialty care segment.Some support3 reports1 development inside
-
Rate cut speculation on August 14, 2025, benefited growth sectors, including healthcare companies like Clover Health, Surgery Partners, Illumina, and Bruker.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Surgery Partners this week
News at the entities that move Surgery Partners most-
SEC StructuralSEC Chair Paul Atkins stated his belief in the need for reassessment of current policies.Moves Surgery Partners
-
Cantor Fitzgerald Mentioned togetherCantor Fitzgerald, led by Gerard Casey, has established an operational presence in Ireland, with offices in Dublin, Limerick, and Cork.Moves Surgery Partners
-
Fifth Third Bancorp TransactionalFifth Third Bancorp boosted its holdings in the NYLIM MacKay Shields Municipal Intermediate ETF, while Cornerstone Advisors cut its position, with filings made to the SEC.Moves Surgery Partners
-
MarketBeat Mentioned togetherMarketBeat used its stock screener tool to highlight Walmart.Moves Surgery Partners
-
FED Shared contextWaller delivered a hawkish speech in London, suggesting a rate hike based on CPI data.Moves Surgery Partners
-
Nasdaq Shared contextTech giants, including Microsoft and Micron, saw sharp declines, dragging the Nasdaq down amid AI trade reversal and Anthropic's failed debut.Moves Surgery Partners
Connections
The 16 strongest of 40, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Eric Evans Structural
Eric Evans holds the role of Chief Executive Officer of Surgery Partners, leading company operations and strategic direction.
-
Bain Capital Transactional
Bain Capital attempted to acquire Surgery Partners, holding a 39% stake before the buyout offer was rejected.
-
Benchmark Mentioned together
Benchmark provides investment ratings and analysis on Surgery Partners.
-
SEC Structural
Surgery Partners is subject to SEC filing requirements for market transparency.
-
TD Cowen Mentioned together
TD Cowen provides financial ratings and price targets for Surgery Partners.
-
Jefferies Financial Group Structural
Analyst reports from Jefferies Financial Group are utilized by the market to influence stock price targets for Surgery Partners.
-
Cantor Fitzgerald Mentioned together
Cantor Fitzgerald provides financial coverage, including 'Overweight' ratings and price targets, for Surgery Partners.
-
FED Shared context
Surgery Partners operates within the macroeconomic environment influenced by FED policy.
Show all 16 connections
-
ASC Operational
Evidence suggests Surgery Partners is strategically targeting ASC's market influence and professional sphere.
-
Raymond James Financial Mentioned together
Raymond James Financial provides market coverage including price targets and ratings for Surgery Partners.
-
Fifth Third Bancorp Transactional
One company increased its holdings in the other company's stock.
-
Nasdaq Shared context
Surgery Partners is a company listed and trades on the Nasdaq stock exchange.
-
UnitedHealth Group Mentioned together
The entities are co-mentioned in the context of the broader health insurance industry and medical costs.
-
Idaho Falls Shared context
Surgery Partners is operating within the geographical context of Idaho Falls, which is the focus of a pending business transaction.
-
MarketBeat Mentioned together
MarketBeat provides analyst ratings and market coverage for Surgery Partners.
-
DoorDash Mentioned together
No evidence provided to determine the relationship between Surgery Partners and DoorDash.
History
Events by the month they beganNovember 2026
1 eventOctober 2026
1 eventSeptember 2026
2 eventsShow 3 earlier months
August 2026
3 events- Surgery Partners is listed on NASDAQ and receives analyst ratings from MarketBeat.
- Cantor Fitzgerald is monitoring the performance of Surgery Partners, a healthcare services provider in the US. Raymond James Financial and TD Cowen are also providing price targets and buy ratings.
- Surgery Partners (Q124668353) is expected to divest from Idaho Falls (Q496360) and operates on the Nasdaq stock exchange (Q82059).
July 2026
2 eventsJune 2026
12 events- Surgery Partners underperformed the market so far this year, based on events of August 5, 2025.
- Eric J. Evans was appointed CEO and Dave Doherty was appointed CFO of Surgery Partners on August 5, 2025.
- A tariff plan could affect the healthcare supply chain, impacting companies like Nobel Biocare and Cardinal Health.
- Surgery Partners and Pacific Biosciences were both mentioned in the context of healthcare industry performance in July 2025.
- Surgery Partners operates across 33 states in the US, and DaVita operates over 2,600 dialysis centers in the US.
- Surgery Partners is headquartered in Brentwood, Tennessee, and uses Replay for conference call distribution.
- Surgery Partners's stock return outpaced the S&P 500 on July 22, 2025.
- Surging medical costs are impacting the health insurance sector, involving companies like UnitedHealth Group, Molina Healthcare, Moderna, Oscar Health, and Surgery Partners.
- Surgery Partners rejected a buyout offer from Bain Capital, while Benchmark reiterated a 'Buy' rating on the company.
- Surgery Partners and Select Medical are identified as operating in the healthcare providers and services segment.
- Surgery Partners and Lifestance Health are partnering, both of which operate in the outpatient and specialty care segment.
- Rate cut speculation on August 14, 2025, benefited growth sectors, including healthcare companies like Clover Health, Surgery Partners, Illumina, and Bruker.